BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET
BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting
BioMarin Announces Positive Pivotal Phase 3 Data for PALYNZIQ® in Adolescents with Phenylketonuria at 15th International Congress of Inborn Errors of Metabolism
